Skip to main content
SpringerLink
Log in

Variation in particular biochemical indicators, cytokine and adipokine profiles of the blood, and the structural and functional parameters of the liver in patients with nonalcoholic fatty liver disease and different genotypes by the polymorphic locus A313G of the GSTP1 gene

  • Published:
Cytology and Genetics Aims and scope Submit manuscript

Abstract

Variation in particular biochemical indicators, cytokine and adipokine profile parameters of the blood, and the structural and functional parameters of the liver have been studied in patients with nonalcoholic fatty liver disease (NAFLD) and different genotypes by the polymorphic locus A313G of GSTP gene (rs 1695). It has been established that the G allele of the GSTP gene (A313G) is significantly more frequently met in NAFLD patients than in healthy individuals. Higher activity of alanine aminotransferase and higher level of leptin, as well as lower adiponectin blood content, were recorded in the carriers of the G allele of the GSTP gene (A313G) as compared to patients with the given gene AA genotype. Higher interleukin-10 blood content was also observed in homozygous G allele carriers of NAFLD patients compared with the patients with the AA and AG genotypes. The patients with the G allele of the GSTP1 gene had a larger right lobe of liver than homozygous carriers of the given gene A allele.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Babak, O.Ya., Kolesnikova, O.V., and Shut, I.V., Influence of the serum adiponectins level on the intensity of nonalcoholic liver steatosis in patients with 2 type diabetes mellitus and excessive body mass, Suchasna Gastroenterologiya, 2011, vol. 57, pp. 5–11.

    Google Scholar 

  2. Conlon, B.A., Beasley, J.M., Aebersold, K., Jhangiani, S.S., and Wylie-Rosett, J., Nutritional management of insulin resistance in nonalcoholic fatty liver disease (NAFLD), Nutrients, 2011, vol. 5, no. 10, pp. 4093–4114.

    Article  Google Scholar 

  3. Bellentani, S., Scaglioni, F., Marino, M., and Bedogni, G., Epidemiology of non-alcoholic fatty liver disease, Dig. Dis., 2010, vol. 28, no. 1, pp. 155–161.

    Article  PubMed  Google Scholar 

  4. Kharchenko, N.V., Anokhina, G.A., Kharchenko, V.V., Opanasyuk, N.D., Lopukh, I., and Korulya, I.A., Peculiarities of the treatment of nonalcoholic steatohepatitis in patients with diabetes mellitus, Suchasna Gastroenterologiya, 2011, vol. 58, pp. 60–64.

    Google Scholar 

  5. Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C., and Marchesini, G., A position statement on NAFLD/ NASH based on the EASL 2009 special conference, J. Hepatol., 2010, vol. 53, no. 2, pp. 372–384.

    Article  PubMed  Google Scholar 

  6. Ozturk, Z.A. and Kadayifci, A., Insulin sensitizers for the treatment of non-alcoholic fatty liver disease, World J. Hepatol., 2014, vol. 6, no. 4, pp. 199–206.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Promrat, K., Kleiner, D.E., Niemeier, H.M., Jackvony, E., Kearns, M., Wands, J.R., Fava, J.L., and Wing, R.R., Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis, Hepatology, 2010, vol. 51, no. 1, pp. 121–129.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Chen, Z.W., Chen, L.Y., Dai, H.L., Chen, J.H., and Fang, L.Z., Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease, J. Zhejiang Univ. Sci. B, 2008, vol. 9, no. 8, pp. 616–622.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Williams, C.D., Stengel, J., Asike, M.I., Torres, D.M., Shaw, J., Contreras, M., Landt, C.L., and Harrison, S.A., Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study, Gastroenterology, 2011, vol. 140, no. 1, pp. 124–131.

    Article  PubMed  Google Scholar 

  10. Wagenknecht, L.E., Scherzinger, A.L., Stamm, E.R., Hanley, A.J., Norris, J.M., Chen, Y.D., Bryer-Ash, M., Haffner, S.M., and Rotter, J.I., Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort, Obesity (Silver Spring), 2009, vol. 17, no. 6, pp. 1240–1246.

    CAS  Google Scholar 

  11. Hayes, J.D., Flanagan, J.U., and Jowsey, I.R., Glutathione transferases, Annu. Rev. Pharmacol. Toxicol., 2005, vol. 45, pp. 51–88.

    Article  CAS  PubMed  Google Scholar 

  12. Sydorchuk, L., Fediv, O., Kohaniuk, J., Sydorchuk, A., Sydorchuk, R., and Fedoniuk, L., Association of glutathione S-transferase gene class T1 (GSTT1) and M1 (GSTM1) with gastroesophageal reflux disease severity and diabetes mellitus, Immunogastroenterology, 2013, vol. 2, no. (2), pp. 109–113.

    Article  Google Scholar 

  13. Strange, R.C., Spiteri, M.A., Ramachandran, S., and Fryer, A.A., Glutathione-S-transferase family of enzymes, Mutat. Res., 2001, vol. 482, nos. 1–2, pp. 21–26.

    Article  CAS  PubMed  Google Scholar 

  14. White, D.L., Li, D., Nurgalieva, Z., and El-Serag, H.B., Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a huge systematic review and meta-analysis, Am. J. Epidemiol., 2008, vol. 167, no. 4, pp. 377–389.

    Article  PubMed  Google Scholar 

  15. Hamajima, N., Takezaki, T., and Tajima, K., Allele frequencies of 25 polymorphisms pertaining to cancer risk for Japanese, Koreans and Chinese, Asian Pac. J. Cancer Prev., 2002, vol. 3, no. 3, pp. 197–206.

    PubMed  Google Scholar 

  16. Wu, K., Wang, X., Xie, Z., Liu, Z., and Lu, Y., Glutathione s-transferase p1 gene polymorphism and bladder cancer susceptibility: an updated analysis, Mol. Biol. Rep., 2013, vol. 40, no. 1, pp. 687–695.

    Article  CAS  PubMed  Google Scholar 

  17. Li, T., Meng. Q.H., Zou, Z.Q., Fan, Y.C., Long, B., Guo, Y.M., Hou, W., Zhao, J., Li, J., Yu, H.W., Zhu, Y.K., and Wang, K., Correlation between promoter methylation of glutathione-S-transferase P1 and oxidative stress in acute-on-chronic hepatitis B liver failure, J. Viral Hepat., 2011, vol. 18, no. 7, pp. 226–231.

    Article  Google Scholar 

  18. Goncharova, I.A., Rachkovskii, M.I., and Beloborodova, E.V., Gamal’ Abd El’-Aziz Nasar, Kh., and Puzyrev, V.P., Liver cirrhosis pathogenetics: polymorphism of glutation s-transferase genes, Mol. Biol. (Moscow), 2010, vol. 44, no. 3, pp. 431–438.

    Article  CAS  Google Scholar 

  19. Buchard, A., Sanchez, J.J., Dalhoff, K., and Morling, N., Multiplex PCR detection of GSTM1, GSTT1, and GSTP1 gene variants, J. Mol. Diagn., 2007, vol. 9, no. 5, pp. 612–617.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Dubovskaya, L.V., Rybina, T.M., Bakakina, Y.S., Kardash, O.F., Denisevich, N.P., and Volotovski, I.D., Role of polymorphism in the CYP1A1, EPHX1 GSTM1, GSTT1 and GSTP1 genes in the development of chronic occupation bronchitis, Ecol. Genet., 2005, vol. 3, pp. 11–17.

    Google Scholar 

  21. Hashemi, M., Eskandari-Nasab, E., Fazaeli, A., Bahari, A., Hashemzehi, N.A., Shafieipour, S., Taheri, M., Moazeni-Roodi, A., Zakeri, Z., Bakhshipour, A., and Ghavami, S., Association of genetic polymorphisms of glutathione-S-transferase genes (GSTT1, GSTM1, and GSTP1) and susceptibility to nonalcoholic fatty liver disease in Zahedan, Southeast Iran, DNA Cell Biol., 2012, vol. 31, no. 5, pp. 672–677.

    Article  CAS  PubMed  Google Scholar 

  22. Liedtke, C. and Trautwein, C., The role of TNF and Fas dependent signaling in animal models of inflammatory liver injury and liver cancer, Eur. J. Cell Biol., 2012, vol. 91, nos. 6–7, pp. 582–589.

    Article  CAS  PubMed  Google Scholar 

  23. Brenner, C., Galluzzi, L., Kepp, O., and Kroemer, G., Decoding cell death signals in liver inflammation, J. Hepatol., 2013, vol. 59, no. 3, pp. 583–594.

    Article  CAS  PubMed  Google Scholar 

  24. Younossi, Z.M., Jarrar, M., Nugent, C., Randhawa, M., Afendy, M., Stepanova, M., Rafiq, N., Goodman, Z., Chandhoke, V., and Baranova, A., A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH), Obes. Surg., 2008, vol. 18, no. 11, pp. 1430–1437.

    Article  PubMed  Google Scholar 

  25. Li, G., Hu, H., Shi, W., Li, Y., Liu, L., Chen, Y., Hu, X., Wang, J., Gao, J., and Yin, D., Elevated hematocrit in nonalcoholic fatty liver disease: a potential cause for the increased risk of cardiovascular disease?, Clin. Hemorheol. Microcirc., 2012, vol. 51, no. 1, pp. 59–68.

    PubMed  Google Scholar 

  26. Paniagua, J.A., Nutrition, insulin resistance and dysfunctional adipose tissue determine the different components of metabolic syndrome, World J. Diabet., 2016, vol. 7, no. 19, pp. 483–514.

    Article  Google Scholar 

  27. Altirriba, J., Poher, A.-L., and Rohner-Jeanrenaud, F., Chronic oxytocin administration as a treatment against impaired leptin signaling or leptin resistance in obesity, Fron. Endocrinol., 2015, vol. 6. doi org/10.3389/fendo.2015.00119

    Google Scholar 

  28. Kaser, S., Moschen, A., Cayon, A., Kaser, A., Crespo, J., Pons-Romero, F., Ebenbichler, C.F., Patsch, J.R., and Tilg, H., Adiponectin and its receptors in non-alcoholic steatohepatitis, Gut, 2005, vol. 54, no. 1, pp. 117–121.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Perumpail, R.B., Liu, A., Wong, R.J., Ahmed, A., and Harrison, S.A., Pathogenesis of hepatocarcinogenesis in non-cirrhotic nonalcoholic fatty liver disease: potential mechanistic pathways, World J. Hepatol., 2015, vol. 7, no. 22, pp. 2384–2388.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bukovinian State Medical University, Chernivtsi, Ukraine

    V. P. Prysyazhnyuk

  2. Reference Center for Molecular Diagnostics, Ministry of Healthcare of Ukraine, Kyiv, Ukraine

    Z. I. Rossokha

  3. Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine

    N. G. Gorovenko

Authors
  1. V. P. Prysyazhnyuk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Z. I. Rossokha
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. G. Gorovenko
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Z. I. Rossokha.

Additional information

Original Ukrainian Text © V.P. Prysyazhnyuk, Z.I. Rossokha, N.G. Gorovenko, 2017, published in Tsitologiya i Genetika, 2017, Vol. 51, No. 6, pp. 50–57.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Prysyazhnyuk, V.P., Rossokha, Z.I. & Gorovenko, N.G. Variation in particular biochemical indicators, cytokine and adipokine profiles of the blood, and the structural and functional parameters of the liver in patients with nonalcoholic fatty liver disease and different genotypes by the polymorphic locus A313G of the GSTP1 gene. Cytol. Genet. 51, 455–461 (2017). https://doi.org/10.3103/S0095452717060111

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.3103/S0095452717060111

Keywords

Search

Navigation